NMOSD Clinical Trials

13 clinical trials for NMOSD across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) — RECRUITING
• A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) — RECRUITING · PHASE3
• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — RECRUITING
• Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases — RECRUITING · NA
• Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD — NOT_YET_RECRUITING · PHASE4
• Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) — NOT_YET_RECRUITING · PHASE3
• Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD — ACTIVE_NOT_RECRUITING · PHASE3
• Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD) — NOT_YET_RECRUITING
• Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder — NOT_YET_RECRUITING
• Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) — NOT_YET_RECRUITING
• A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention — TERMINATED · PHASE4
• Comparative Study on AQP4 Antibody Detection Methods — ACTIVE_NOT_RECRUITING

Refine this search